NCCN Clinical Practice Guidelines in Oncology Symposium: Colon, Rectal, & Anal Cancers – Adjuvant Therapy for Locoregional Colon Cancer

Download Podcast

Listen to MP3

Podcast Evaluation

Recorded at a symposium held in Washington, DC, on November 5, 2007

Presenter

Paul F. Engstrom, MD
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Faculty Disclosure Statement

Dr. Engstrom has disclosed that he has no financial interests, arrangements, or affiliations with the manufacturer of products and devices to be discussed in his presentation or who may financially support the educational activity.

Dr. Engstrom has indicated that his presentation will not include discussion of investigational or unlabeled uses of a product.

Program Overview

NCCN, drawing on the expertise of faculty from its 21 Member Institutions, has developed and maintains clinical practice guidelines addressing colon cancer as part of its complete library of NCCN Clinical Practice Guidelines in Oncology™.  This program will present the algorithm and focus on new approaches to adjuvant therapy for colon cancer that have been incorporated into the pathway.

Educational Objectives

Following this activity, participants should be able to:

• Outline the appropriate workup for patients with colon carcinomas
• Describe the current status of adjuvant chemotherapy for Stage II and III colon cancer

Intended Audience

This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer.

Activity Instructions

Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation.  Participants should review the learning objectives and faculty disclosure statements prior to listening to a presentation in its entirety.  You must be connected to the Internet in order to review and complete the evaluation form.  A statement of credit will be electronically generated once you complete the evaluation form.  To receive credit, this activity must be completed no later than December 28, 2008.  There is no fee for participating in this activity.

Download Podcast

Listen to MP3

Podcast Evaluation

Accreditation Information

Physicians

The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NCCN designates this educational activity for a maximum of 0.5 AMA PRA Category 1
Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

This activity is approved for 0.5 contact hours.  National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Release date:  December 28, 2007
Expiration date:  December 28, 2008

Commercial Support

Distribution supported by educational grants from Amgen Oncology, Bristol-Myers Squibb Company, Genentech BioOncology, ImClone Systems Incorporated, Pfizer Inc., Roche Laboratories Inc., and sanofi-aventis U.S.